Men With Organ-confined Prostate Cancer and Positive Surgical Margins Develop Biochemical Failure at a Similar Rate to Men With Extracapsular Extension

被引:31
|
作者
Psutka, Sarah P.
Feldman, Adam S.
Rodin, David
Olumi, Aria F.
Wu, Chin-Lee
McDougal, W. Scott [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Dept Urol, Sch Med, Boston, MA 02114 USA
关键词
RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; PATHOLOGICAL STAGE; ANTIGEN RECURRENCE; NATURAL-HISTORY; PROGRESSION; IMPACT; SPECIMENS; DATABASE;
D O I
10.1016/j.urology.2010.10.036
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To define the role of positive surgical margins (PSMs) after radical retropubic prostatectomy as a predictor of biochemical failure (BCF) in prostate cancer with respect to pathologic stage. METHODS A retrospective cohort study of 300 patients who had undergone radical retropubic prostatectomy from 1993 to 1995 was performed. The role of margin status and the length of the PSM in the progression to BCF was defined after controlling for the preoperative prostate-specific antigen level, Gleason score, tumor stage, tumor volume, seminal vesical invasion, lymphovascular invasion, and perineural invasion using a multivariate regression model. The median follow-up time was 12 years. RESULTS The presence of PSMs correlated with a shorter time to BCF in men with Stage pT2 disease (P < .0001) but not in men with Stage pT3 disease (P = .66). Of the patients with Stage pT2 disease and PSMs, the PSM length did not correlate with progression to BCF. PSMs predicted a shorter time to progression to BCF in patients with high-and low-volume pT2 disease (P = .0261 and P = .0003, respectively). Only PSMs predicted a shorter time to BCF on multivariate analysis in patients with Stage pT2 cancer (hazard ratio 2.33, 95% confidence interval 1.495-3.723). In patients with Stage pT3 disease, PSMs were not associated with an increased risk of BCF (hazard ratio 0.747, 95% confidence interval 0.328-1.703). CONCLUSIONS Surgical margin status did not affect the risk of BCF in patients with Stage pT3a disease; however, it did affect patients with Stage pT2 disease, irrespective of PSM length or disease volume. During 12 years of follow-up, the patients with PSMs and Stage pT2 disease had a risk of BCF similar to that of the patients with Stage pT3 disease. UROLOGY 78: 121-125, 2011. (C) 2011 Elsevier Inc.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [1] The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml
    Eminaga, Okyaz
    Hinkelammert, Reemt
    Titze, Ulf
    Abbas, Mahmoud
    Eltze, Elke
    Bettendorf, Olaf
    Semjonow, Axel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 32.e17 - 32.e25
  • [2] Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer
    Song, Cheryn
    Kang, Taejin
    Yoo, Sangjun
    Jeong, In Gab
    Ro, Jae Y.
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 168 - 174
  • [3] Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer
    Salomon, L
    Anastasiadis, AG
    Antiphon, P
    Levrel, O
    Saint, F
    De La Taille, A
    Cicco, A
    Vordos, D
    Hoznek, A
    Chopin, D
    Abbou, CC
    UROLOGIA INTERNATIONALIS, 2003, 70 (04) : 291 - 296
  • [4] Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer
    Takashi Kobayashi
    Kent Kanao
    Motoo Araki
    Naoki Terada
    Yasuyuki Kobayashi
    Atsuro Sawada
    Takahiro Inoue
    Shin Ebara
    Toyohiko Watanabe
    Tomomi Kamba
    Makoto Sumitomo
    Yasutomo Nasu
    Osamu Ogawa
    International Journal of Clinical Oncology, 2018, 23 : 347 - 352
  • [5] Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer
    Kobayashi, Takashi
    Kanao, Kent
    Araki, Motoo
    Terada, Naoki
    Kobayashi, Yasuyuki
    Sawada, Atsuro
    Inoue, Takahiro
    Ebara, Shin
    Watanabe, Toyohiko
    Kamba, Tomomi
    Sumitomo, Makoto
    Nasu, Yasutomo
    Ogawa, Osamu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 347 - 352
  • [6] Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer
    Kim, Yunee
    Ignatchenko, Vladimir
    Yao, Cindy Q.
    Kalatskaya, Irina
    Nyalwidhe, Julius O.
    Lance, Raymond S.
    Gramolini, Anthony O.
    Troyer, Dean A.
    Stein, Lincoln D.
    Boutros, Paul C.
    Medin, Jeffrey A.
    Semmes, O. John
    Drake, Richard R.
    Kislinger, Thomas
    MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (12) : 1870 - 1884
  • [7] Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer
    Salomon, L
    Anastasiadis, AG
    Levrel, O
    Katz, R
    Saint, F
    de la Taille, A
    Cicco, A
    Vordos, D
    Hoznek, A
    Chopin, D
    Abbou, CC
    UROLOGY, 2003, 61 (02) : 386 - 390
  • [8] Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer
    Ahyai, Sascha A.
    Zacharias, Mario
    Isbarn, Hendrik
    Steuber, Thomas
    Eichelberg, Christian
    Koellermann, Jens
    Fisch, Margit
    Karakiewicz, Pierre I.
    Huland, Hartwig
    Graefen, Markus
    Chun, Felix K. -H.
    BJU INTERNATIONAL, 2010, 106 (04) : 478 - 483
  • [9] Radiotherapy of organ-confined prostate cancer: Biochemical failure definitions and risk groups
    Thames, H
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S28 - S28
  • [10] Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification
    Abdollah, Firas
    Sun, Maxine
    Suardi, Nazareno
    Gallina, Andrea
    Capitanio, Umberto
    Bianchi, Marco
    Tutolo, Manuela
    Fossati, Nicola
    Castiglione, Fabio
    Freschi, Massimo
    Karakiewicz, Pierre
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1497 - 1503